ObjectiveThe aim of this study was to identify whether revascularization by percutaneous transluminal angioplasty (PTA) for patients with intermittent claudication improved measures of functional performance including balance.MethodsA prospective observational study was performed at a single tertiary vascular center. Patients with symptomatic intermittent claudication (Rutherford grades 1-3) were recruited to the study. Participants were assessed at baseline (pre-PTA) and then 3, 6, and 12 months post-PTA for markers of (1) lower limb ischemia (treadmill walking distances and ankle-brachial pressure index), (2) physical function (6-minute walk, Timed Up and Go, and chair stand time), (3) balance impairment using computerized dynamic posturo...
Objective:To determine quality of life in claudicants before and after percutaneous transluminal ang...
AbstractBackground and Objective: intermittent claudication is associated with a significant reducti...
AbstractBackgroundUncertainty exists on whether there is adjuvant benefit of percutaneous translumin...
Objective The aim of this study was to identify whether revascularization by percutaneous translumin...
ObjectiveThe aim of this study was to identify whether revascularization by percutaneous translumina...
AbstractPurpose: Percutaneous transluminal angioplasty (PTA) is an increasingly popular invasive tre...
The aim of this study was to explore the effects during 12 months follow-up of 12 weeks of supervise...
Objectives:this study aims to assess the impact of PTA on the quality of life (QoL) of claudicants a...
Objectives:this study aims to assess the impact of PTA on the quality of life (QoL) of claudicants a...
Objectives:To measure changes in claudicant's quality of life after surgery, angioplasty or unsuperv...
The aim of this study was to explore the effects during 12 months follow-up of 12 weeks of supervise...
Objectives:To determine differences between PTA and conventional medical treatment in treadmill dist...
Objective:As intermittent claudication (IC) infrequently progresses to limb loss many clinicians ado...
Purpose: To compare clinical success, functional capacity, and quality of life during 12 months afte...
Objective: To provide an overview of therapies for improving functional outcomes in individuals with...
Objective:To determine quality of life in claudicants before and after percutaneous transluminal ang...
AbstractBackground and Objective: intermittent claudication is associated with a significant reducti...
AbstractBackgroundUncertainty exists on whether there is adjuvant benefit of percutaneous translumin...
Objective The aim of this study was to identify whether revascularization by percutaneous translumin...
ObjectiveThe aim of this study was to identify whether revascularization by percutaneous translumina...
AbstractPurpose: Percutaneous transluminal angioplasty (PTA) is an increasingly popular invasive tre...
The aim of this study was to explore the effects during 12 months follow-up of 12 weeks of supervise...
Objectives:this study aims to assess the impact of PTA on the quality of life (QoL) of claudicants a...
Objectives:this study aims to assess the impact of PTA on the quality of life (QoL) of claudicants a...
Objectives:To measure changes in claudicant's quality of life after surgery, angioplasty or unsuperv...
The aim of this study was to explore the effects during 12 months follow-up of 12 weeks of supervise...
Objectives:To determine differences between PTA and conventional medical treatment in treadmill dist...
Objective:As intermittent claudication (IC) infrequently progresses to limb loss many clinicians ado...
Purpose: To compare clinical success, functional capacity, and quality of life during 12 months afte...
Objective: To provide an overview of therapies for improving functional outcomes in individuals with...
Objective:To determine quality of life in claudicants before and after percutaneous transluminal ang...
AbstractBackground and Objective: intermittent claudication is associated with a significant reducti...
AbstractBackgroundUncertainty exists on whether there is adjuvant benefit of percutaneous translumin...